Raymond James & Associates Zoetis Inc. Transaction History
Raymond James & Associates
- $161 Billion
- Q3 2024
A detailed history of Raymond James & Associates transactions in Zoetis Inc. stock. As of the latest transaction made, Raymond James & Associates holds 925,354 shares of ZTS stock, worth $169 Million. This represents 0.11% of its overall portfolio holdings.
Number of Shares
925,354
Previous 794,419
16.48%
Holding current value
$169 Million
Previous $138 Million
31.28%
% of portfolio
0.11%
Previous 0.09%
Shares
30 transactions
Others Institutions Holding ZTS
# of Institutions
1,921Shares Held
424MCall Options Held
1.15MPut Options Held
1.2M-
Vanguard Group Inc Valley Forge, PA41.2MShares$7.53 Billion0.14% of portfolio
-
Black Rock Inc. New York, NY36.8MShares$6.73 Billion0.15% of portfolio
-
State Street Corp Boston, MA19.7MShares$3.6 Billion0.15% of portfolio
-
State Farm Mutual Automobile Insurance CO Bloomington, IL16.2MShares$2.95 Billion2.53% of portfolio
-
Bank Of America Corp Charlotte, NC15.1MShares$2.76 Billion0.23% of portfolio
About Zoetis Inc.
- Ticker ZTS
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 468,139,008
- Market Cap $85.5B
- Description
- Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...